Trademarkia Logo

Canada

C$
OLATEC
REGISTERED

on 8 Apr 2024

Last Applicant/ Owned by

OLATEC THERAPEUTICS LLC

800 Fifth Avenue, 25 FloorNew York, NY 10065

US

Serial Number

1956393 filed on 9th Apr 2019

Registration Number

TMA1228621 registered on 8th Apr 2024

Registration expiry Date

8th Apr 2034

Correspondent Address

OYEN WIGGS GREEN & MUTALA LLP

480-THE STATION, 601 WEST CORDOVA STREETVANCOUVER

BRITISH COLUMBIA

CA

V6B1G1

OLATEC

Trademark usage description

analgesics; anti-inflammatories; anti-inflammatory pharmaceuticals; chemical compounds for use in the manufacture of pharmaceuticals, namely, analgesi Read More

Classification Information


Class [005]
Analgesics; Anti-inflammatories; Anti-inflammatory pharmaceuticals; Chemical compounds for use in the manufacture of pharmaceuticals, namely, analgesics; Anti-inflammatory preparations and chemical compounds for use in the manufacture of pharmaceuticals; Pharmaceutical preparations and products for the prevention of pain; Pharmaceutical preparations and products for the prevention of diseases, namely, inflammatory disorders and conditions, namely inflammatory arthritis, inflammatory cardiovascular disorders, cancer, diabetes, Alzheimer's disease, inflammatory pelvic diseases, inflammatory connective tissue diseases and injuries, inflammatory skin diseases, inflammatory bowel diseases, inflammatory muscle diseases and disorders, musculoskeletal sprains, musculoskeletal strains, tendonopathy, peripheral radiculopathy, rheumatoid arthritis, polymyalgia rheumatica, juvenile arthritis, gout, ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus, costochondritis, tendonitis, bursitis, osteoarthritis, dermatitis, acne, psoriasis; Pharmaceutical preparations and products for the prevention of diseases, namely, pain in humans and animals; Pharmaceutical preparations and substances for the treatment of pain; Pharmaceutical preparations and substances for the treatment of inflammatory disorders and diseases, namely inflammatory arthritis, inflammatory cardiovascular disorders, cancer, diabetes, Alzheimer's disease, inflammatory pelvic diseases, inflammatory connective tissue diseases and injuries, inflammatory skin diseases, inflammatory bowel diseases, inflammatory muscle diseases and disorders, musculoskeletal sprains, musculoskeletal strains, tendonopathy, peripheral radiculopathy, rheumatoid arthritis, polymyalgia rheumatica, juvenile arthritis, gout, ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus, costochondritis, tendonitis, bursitis, osteoarthritis, dermatitis, acne, psoriasis; Therapeutic pharmaceutical preparations and substances for the treatment of pain and inflammation; Pharmaceutical preparations and products for medical purposes for treating pain; Pharmaceutical preparations and products for medical purposes for treating inflammatory disorders and conditions in humans and animals, namely inflammatory arthritis, inflammatory cardiovascular disorders, cancer, diabetes, Alzheimer's disease, inflammatory pelvic diseases, inflammatory connective tissue diseases and injuries, inflammatory skin diseases, inflammatory bowel diseases, inflammatory muscle diseases and disorders, musculoskeletal sprains, musculoskeletal strains, tendonopathy, peripheral radiculopathy, rheumatoid arthritis, polymyalgia rheumatica, juvenile arthritis, gout, ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus, costochondritis, tendonitis, bursitis, osteoarthritis, dermatitis, acne, psoriasis


Classification kind code

11

Mark Details


Serial Number

1956393

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 10th Jan 2024
Advertised
Submitted for opposition 27
on 14th Dec 2023
Approval Notice Sent
Submitted for opposition 26
on 14th Dec 2023
Approved
Submitted for opposition 22
on 28th Aug 2023
Search Recorded
Submitted for opposition 20
on 28th Aug 2023
Examiner's First Report
Submitted for opposition 287
on 30th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 48
on 7th Jan 2022
Agent Changed
Submitted for opposition 31
on 12th Apr 2019
Formalized
Submitted for opposition 1
on 10th Apr 2019
Created
Submitted for opposition 30
on 9th Apr 2019
Filed